In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Solvay agrees to acquire Fournier

Executive Summary

To strengthen its cardiology business and research pipeline, Solvay has signed a memorandum of understanding to buy Fournier Pharma for €1.3bn ($2.1bn) in cash. Both have portfolios of drugs to treat cardiovascular, gastroenterological, psychiatric, and gynecological conditions.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Preliminary
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies